 NANJING, China--BUSINESS WIRE--Genetron Holdings Limited Genetron Health or the Company Nasdaq: GTH, a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. CTTQ, a subsidiary of Sino Biopharmaceutical Limited Sino Biopharm HKEX: 1177, today announced an exclusive strategic partnership agreement for HCCscree 